B+
Bull case
30%
Probability
Target price
$1,600.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
MTD
Mettler-Toledo InternationalBNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
The post-earnings update confirms better-than-expected organic growth, adjusted EPS of $11.46 versus stored consensus of $10.78, higher full-year guidance, improving China and emerging-market demand, and multiple positive post-print target revisions. The prior neutral thesis has shifted modestly positive.
Posture
Constructive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.3.
What can break
At $1,445, the stock is near the stored median target, increasing downside risk if guidance execution or market recovery slows.
Momentum
96
Value
60
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $1,496.00 · Bull $1,600.00 · Bear $1,340.00Analysis 2026-08-04; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-27 • Vendor: Data Vendor v1
Scores
As of 2026-10-27 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-27
Investment thesis
As of 2026-10-27
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-27. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $1,555.27
Why
Momentum96 · Δ7d +2.9
Value60 · Δ7d -0.3
Sentiment46 · Δ7d -3.8
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta -0.3.
Contradictions & invalidation
- • At $1,445, the stock is near the stored median target, increasing downside risk if guidance execution or market recovery slows.
- • Management says market conditions remain uncertain and could change quickly. [#SEC-8K-2026-07-30]
- • The company remains exposed to uncertain macro conditions, tariffs and policy changes, regional demand variability, and execution risk.
Catalyst clock
2026-07-30
Q2 2026 beat and full-year guidance raise
Lead driver: Value · See fundamentals
Momentum
96
8% active weight
Current posture
7d trendImproving
Δ7d
+2.9
Δ21d
+6.4
Value
60
47% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-1.1
Sentiment
46
45% active weight
Current posture
7d trendSoftening
Δ7d
-3.8
Δ21d
-16.5
Why this grade
Composite grade B. Momentum 96.0 / Value 59.9 / Sentiment 45.8
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$1,496.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$1,340.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-27
Fundamentals (TTM)
As of 2026-10-27
Market Cap
$33.77B
Beta
1.43
Shares Out
20.04M
P/E (TTM)
36.1
P/S (TTM)
7.50
P/FCF (TTM)
33.22
Rev YoY
+4.5%
EPS YoY
+18.4%
Gross Margin
+58.4%
Op Margin
+28.4%
Net Debt
$2.2B
Current Ratio
1.12
As of 2026-10-27 • Updated nightlySource: Internal modelMethods & Data